ETFChannel.com
TXG Description — 10x Genomics Inc

10x Genomics is a life science technology company. Co.'s integrated platform solutions include instruments, consumables and software. Co.'s commercial product portfolio utilizes its Chromium X Series and Chromium Connect, its Visium CytAssist, an instrument designed to simplify the Visium solution workflow, its Xenium Analyzer, an instrument designed for high-throughput analysis of cells in their tissue environment, and its proprietary microfluidic chips, slides, reagents and other consumables for its Chromium, Visium and Xenium solutions. Co. bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization.

Company Name: 
10x Genomics Inc
Website: 
www.10xgenomics.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding TXG: 
36
Total Market Value Held by ETFs: 
$438,254,350.72
Total Market Capitalization: 
$2,838,000,000
% of Market Cap. Held by ETFs: 
15.44%
 ETF   TXG Weight   TXG Amount 
 ARKK   1.90%   $126,502,078         
 VTI   0.00%   $74,886,639         
 VB   0.04%   $61,461,963         
 ARKG   3.36%   $47,626,098         
 VXF   0.04%   $39,696,600         
 VBK   0.10%   $34,792,861         
 IWP   0.07%   $10,287,868         
 IWF   0.01%   $7,831,694         
 VHT   0.04%   $7,684,936         
 IWR   0.02%   $7,065,633         
List of all 36 ETFs holding TXG »
Quotes delayed 20 minutes

Email EnvelopeFree TXG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.15 out of 4)
36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding TXG | 10x Genomics Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.